Methods and Results Forms

Results Forms

Scheme result forms will no longer be printed and included in the box with distributed samples. Please find below electronic forms for reporting your results for each of our schemes. The sample IDs for each distribution can be found on the sample labels as well as the distribution/deadline timetable on pages 52-53 of our Participants Manual. Results must be submitted by the results deadline for each distribution.

Method Forms

Detailed method information is now collected on separate forms to the scheme results. This must be completed with the first submission of sample results each year and after any changes to testing methodology during the current year.

PLEASE NOTE: This is NOT online data entry, you are still required to send a copy of your results to us.

Click the link to the relevant form to open. The forms are in ‘Microsoft Word’ format which allow results to be directly typed into them. When completed, please submit a copy to us. We would encourage result submission by e-mail where possible. If you are unsure of your lab name or lab number or have any problems, please contact us using ukneqashandi@wales.nhs.uk.

Please check the current version of the form you are using to ensure it is the correct and most up-to-date version. Results submitted on non-official or outdated forms will not be accepted for assessment.

Scheme 1A - HLA Phenotyping
Scheme 1B - HLA-B27 Testing
Scheme 2A - Cytotoxic Crossmatching
Scheme 2B - Crossmatching by Flow Cytometry
Scheme 3 - HLA Antibody Specificity Analysis
Scheme 4A1 - DNA HLA Typing at 1st Field Resolution
Scheme 4A2 - DNA HLA Typing at 2nd Field Resolution
Scheme 4B - ABO Grouping by DNA-based Methods
Scheme 6 - HLA Antibody Detection
Scheme 7 - HLA-B*57:01 Typing for Drug Hypersensitivity
Scheme 8 - HLA and Disease Typing for HLA-DR/DQ/DP only
Scheme 9 - KIR Genotyping
Scheme 10 - HPA Genotyping

Copyright © All UK NEQAS for H&I reports and result summaries are confidential. No data may be distributed, published or used for publicity and promotion in any form without the written consent of the Scheme Director on each and every occasion.